Home›Companies›Biotech & Pharma›Perceive Biotherapeutics

Perceive Biotherapeutics, Inc.

Updated Oct 27, 2026·Latest SEC filing Jan 13, 2023·Suggest an edit

About Perceive Biotherapeutics

Perceive Biotherapeutics is a private company based in South San Francisco, California, incorporated in 2020 in Delaware. It has reported $39,999,986 raised in one offering on Form D since January 2023. Its chief executive is Kirsten Macfarlane.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Dec 29, 2022Jan 13, 2023$39,999,986of $77.9M target6$6.6MEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Perceive Biotherapeutics's Form D filed Jan 13, 2023.

WD
Watson Debi
Director
AR
Anne Rubin
Executive officer and director
KM
Kirsten Macfarlane
CEO and director
CW
RO
RJ

Sources

  1. SECPerceive Biotherapeutics, Inc. filing history